Form D — Delfi Diagnostics, Inc.
0000905148-25-004422 · filed Dec 18, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $60,000,000
- Reported amount sold
- $34,333,315
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Delfi Diagnostics, Inc.
- CIK
- 1783735
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1810 Embarcadero Road
Palo Alto, California 94303 - Phone
- 410-961-9015
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Susan Tousi · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Peter B. Bach · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Amoolya Singh · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Lee-Ann Smith-Freeman · Executive OfficerPalo Alto, California Find on LinkedIn ↗
-
Victor Velculescu · DirectorPalo Alto, California Find on LinkedIn ↗
-
Greg Yap · DirectorPalo Alto, California Find on LinkedIn ↗
-
Rishi Gupta · DirectorPalo Alto, California Find on LinkedIn ↗
-
Michael Dybbs · DirectorPalo Alto, California Find on LinkedIn ↗
-
Elizabeth Homans · DirectorPalo Alto, California Find on LinkedIn ↗
-
Justin Kao · DirectorPalo Alto, California Find on LinkedIn ↗
-
Jacob Van Naarden · DirectorPalo Alto, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗